We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

012750:KRXS-1 Corporation Analysis

Data as of 2026-06-11 - not real-time

₩76,700.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

The 20‑day and 50‑day simple moving averages remain above the current price, creating a neutral to mildly bullish bias, while the 200‑day average also supports this view. RSI sits in the mid‑50s, indicating the stock is neither overbought nor oversold. The MACD histogram is positive and the signal line has turned bullish, suggesting upward momentum. Volume trends are increasing, adding conviction to the price action. The forward P/E is well below the industry average, pointing to a clear valuation gap. With a dividend yield exceeding four percent and a payout ratio comfortably under seventy percent, the dividend appears sustainable.
Beta is exceptionally low, implying limited sensitivity to market swings, yet the recent 30‑day price volatility is high, reflecting short‑term price swings. The DCF‑derived fair value sits modestly above the market price, indicating upside potential of roughly twenty percent. Strong operating cash flow and a modest debt load provide balance‑sheet resilience. Regulatory risk in the security services sector is moderate, but the overall environment remains stable. These fundamentals together support a buy recommendation across short, medium, and long horizons.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD histogram with signal line turn
  • Increasing volume supporting price strength
  • Attractive dividend yield with sustainable payout

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervaluation relative to DCF fair value and industry P/E
  • Strong operating cash flow and low debt
  • Low beta indicating limited market risk

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable dividend income stream
  • Stable sector fundamentals and regulatory environment
  • Potential upside of over twenty percent based on valuation gap

Key Metrics & Analysis

Financial Health

Revenue Growth-0.10%
Profit Margin5.47%
P/E Ratio13.8
ROE9.63%
ROA5.27%
Debt/Equity3.37
Op. Cash Flow₩371.7B
Free Cash Flow₩134.4B
Industry P/E30.4

Technical Analysis

TrendNeutral
RSI55.2
Support₩66,800.00
Resistance₩76,700.00
MA 20₩71,540.00
MA 50₩79,938.00
MA 200₩79,657.50
MACDBullish
VolumeIncreasing
Fear & Greed Index86.71

Valuation

Fair Value₩77,855.44
Target Price₩94,312.50
Upside/Downside22.96%
GradeUndervalued
TypeValue
Dividend Yield4.17%

Risk Assessment

Beta0.15
Volatility55.93%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.